Show simple item record

Authordc.contributor.authorVidal Álvarez, Roberto 
Authordc.contributor.authorCaballero, B. es_CL
Authordc.contributor.authorCouve Correa, Andrés es_CL
Authordc.contributor.authorHetz Flores, Claudio es_CL
Admission datedc.date.accessioned2011-11-25T16:18:21Z
Available datedc.date.available2011-11-25T16:18:21Z
Publication datedc.date.issued2011
Cita de ítemdc.identifier.citationCurrent Molecular Medicine, 2011, Vol. 11, No. 1es_CL
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/128910
General notedc.descriptionArtículo de publicación ISIes_CL
Abstractdc.description.abstractA variety of neurological diseases including Huntington’s disease (HD), Alzheimer’s disease and Parkinson’s disease share common neuropathology, primarily featuring the presence of abnormal protein inclusions containing specific misfolded proteins. Mutations leading to expansion of a poly-glutamine track in Huntingtin cause HD, and trigger its misfolding and aggregation. Recent evidence indicates that alterations in the secretory pathway, in particular the endoplasmic reticulum (ER), are emerging features of HD. Although it is not clear how cytoplasmic/nuclear located mutant Huntingtin alters the function of the ER, several reports indicate that mutant Huntingtin affects many essential processes related to the secretory pathway, including inhibition of ER-associated degradation, altered ER/Golgi vesicular trafficking and axonal transport, disrupted autophagy and abnormal ER calcium homeostasis. All these alterations are predicted to have a common pathological outcome associated to disturbance of protein folding and maturation pathways at the ER, generating chronic ER stress and neuronal dysfunction. Here, we review recent evidence involving ER stress in HD pathogenesis and discuss possible therapeutic strategies to target organelle function in the context of disease.es_CL
Patrocinadordc.description.sponsorshipThis work was primarily supported by High Q Foundation and CHDI Foundation Inc. In addition we thank support from FONDECYT no. 110017, FONDAP grant no. 15010006, Millennium Nucleus no. P07-048- F, Michael J. Fox Foundation for Parkinson's Research, Alzheimer’s Association, Genzyme, and ICGEB (CH); FONDECYT no. 1100137 (AC) and FONDECYT no. 3100039 (RV).es_CL
Lenguagedc.language.isoenes_CL
Publisherdc.publisherBentham Science Publishers Ltd.es_CL
Keywordsdc.subjectHuntington's diseasees_CL
Títulodc.titleConverging Pathways in the Occurrence of Endoplasmic Reticulum (ER) Stress in Huntington’s Diseasees_CL
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record